Pathogenesis
Diabetes emerges through a combined effect of genetic inheritance and exposure to environmental factors plus immunity issues. Type 1 diabetes occurs more frequently in people who inherit particular genetic traits. The immune system damages insulin-making cells unintentionally, leading to low insulin production or none at all in the body. The body develops diabetes because insulin deficiency stops sugar from being used as energy and leads to elevated blood sugar levels. (Stumvoll et al. 2008).
T2DM develops because insulin stops working effectively as the body cells resist its actions. The body blocks insulin signals at three key locations: muscles, the liver, and body fat. When the pancreas fails to produce enough insulin, the organ increases its insulin production output. Prolonged pancreatic cell strain causes insulin production to decline and produces abnormal increases in blood sugar levels. Fat storage and inflammation in our liver and muscle tissues reduce insulin's effectiveness. The PI3K/Akt and MAPK pathways actively support body functions of T2DM by controlling sugar uptake and cell development. The breakdown of these cell-signaling pathways creates insulin resistance and health difficulties.
Clinical Correlation
Diabetes symptoms result directly from how diabetes develops and progresses. The medical condition T1DM develops when insulin-producing cells get damaged and causes people to urinate more often, feel strongly thirsty, lose weight, and feel exhausted. People with type 1 diabetes experience an increased risk of developing celiac disease and thyroid disease because type 1 diabetes results from an autoimmune response. The signs of T2DM include tiredness alongside eye clarity issues and repeated infections because the body cannot make enough insulin and resist the insulin it receives effectively. Individuals with T2DM typically gain excess weight and develop dark skin discoloration because their bodies resist insulin effects.
Doctors and nurses can better diagnose and treat diabetes when they understand its molecular processes. A test for autoantibodies helps doctors find T1DM patients before their full symptoms show up. People with T1DM can better control their diabetes through main treatment insulin therapy alongside modern insulin pumps and continuous glucose monitors. Patients with T2DM need to change their diet and exercise habits to help their body work better with insulin. Doctors use metformin and GLP-1 receptor agonists as medicines to control blood sugar levels through multiple metabolic actions in the body.
Conclusion
Embracing unhealthy lifestyle patterns while inheriting specific genes leads to diabetes and limits insulin's effectiveness. In Type 1 diabetes insulin-producing cells must endure damage to develop this condition yet Type 2 diabetes results from insulin resistance. Effective patient care depends on advanced practice nurses that are familiar on how diabetes changes the way the body functions. Medical staff use their understanding of diabetes biology to provide better help patients who have diabetes lead healthier lives.
References
Bielka, W., Przezak, A., & Pawlik, A. (2022). The role of the gut microbiota in the pathogenesis of diabetes. International journal of molecular sciences, 23(1), 480.
Guo, H., Wu, H., & Li, Z. (2023). The pathogenesis of diabetes. International journal of molecular sciences, 24(8), 6978.
Stumvoll, M., Goldstein, B. J., & van Haeften, T. W. (2008). Type 2 diabetes: pathogenesis and treatment. The Lancet, 371(9631), 2153-2156.